Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Recurrence 1Glioma 1Colorectal Adenocarcinoma 1Brain Neoplasms 1Anxiety Disorders 1

Interventions

pembrolizumab 1281Specimen Handling 927Carboplatin 835Magnetic Resonance Spectroscopy 834Cyclophosphamide 809Cisplatin 733Nivolumab 683Paclitaxel 638Radiotherapy 614Gemcitabine 582Biopsy 558Bevacizumab 482Dexamethasone 446fludarabine 411Docetaxel 385venetoclax 371Oxaliplatin 368Capecitabine 364Fluorouracil 360atezolizumab 346durvalumab 340Rituximab 334Drug Therapy 332Doxorubicin 319Blood Specimen Collection 317Radiosurgery 317Standard of Care 311Pemetrexed 307Ipilimumab 306Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Fluoxetine × 1 year × Clear all
NCT06225011 2026-05-11

Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer

Jonsson Comprehensive Cancer Center

Phase 1 Recruiting
10 enrolled
Gastrointestinal

Colorectal Adenocarcinoma

NCT07174947 2026-03-24

SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety

First Affiliated Hospital of Wenzhou Medical University

Phase 2 Recruiting
240 enrolled

Anxiety Disorders

NCT05634707 2025-09-22

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Duke University

Phase EARLY_PHASE1 Active not recruiting
10 enrolled
CNS

Brain Neoplasms, Glioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡